Prenetics Global Limited

PRE Consumer Defensive Packaged Foods

Prenetics Global Limited’s revenue for fiscal 2025 (year ended December 2025) was $92.4 million, up 479.8% from fiscal 2024.

Revenue
+288.6%
EPS
+44.7%
Free cash flow
−297.2%

Quarter to June 2026, against a year earlier

16.24 0.20 +1.25%
Market cap
$273.0M
P/E
0.0×
Fwd P/E
−5.2×
Dividend yield
—
F-score
5/9
Altman Z
n/a
Beneish M
0.84
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 1.00
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — 2 — — —
Sell — — — — — — — — — — — —
Insider Ownership 24.13%

Capital & Financial Ratios $m

Size
Market Cap 273.04
Revenue ttm 154.59
Net income ttm (48.32)
Free cash flow ttm (88.10)
Net debt Q (59.05)
Valuation
P/E 0.00
Forward P/E (5.17) (negative: loss-making)
Price / sales 1.81
Forward P/S Powerpack
Price / FCF 0.00
Price / book 3.02
Financial health
Current ratio Q 4.04 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q —
Growth
Revenue growth Q +288.57% (above 0%: growing)
Operating income growth Q −144.64% (below 0%: shrinking)
EPS, this year +7.33%
EPS, next year A +49.79% (at or above 15%: strong)
Revenue, next year A −99.99% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +54.25% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 7.85%
10-year low 10-year high
P/B against its own 10 years 85.13%
10-year low 10-year high
EV/Sales against its own 10 years 42.02%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—
Growth, 2016–20
−100.0%/yr
  1. 10.50 ’16
  2. 0.00 ’18 −100
  3. 0.00 ’19
  4. 0.00 ’20
paid change on the year, %

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 62 52 32 59
Receivables 4 5 3 5
Inventory 3 7 7 14
Other 16 19 43 70
94 86 85 148
2023 2024 2025 Q'26
Payables 2 4 3 1
ST’ Debt — — — —
Other 6 6 3 4
39 37 29 37

Compound Annual Growth %

10y 5y 3y
Sales — — 91.46%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — (12.92%) (13.72%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (1.36) (0.52) — — —
’25 (0.80) (0.94) (0.53) (0.47) (2.68)
’24 (0.70) (0.88) (0.84) (1.38) (3.71)
’23 (1.05) (2.10) (1.16) (1.57) (5.58)
’22 (15.85) (43.63) (3.15) 0.15 (37.48)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 36 46 — — —
’25 8 12 24 49 92
’24 6 3 4 3 16
’23 5 7 5 5 22
’22 92 4 4 (87) 13
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (12) (16) — — —
’25 (4) (5) — (22) (22)
’24 — — — (29) (29)
’23 — — — (14) (14)
’22 0 — — 15 15
’21 — (1) 0 0 (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (12) (16) — — —
’25 (4) (5) — (22) (76)
’24 — — — (29) (30)
’23 — — — (14) (15)
’22 0 — — 15 8
’21 — (1) 0 0 (1)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — 276 13 22 16 92 155 (23.9%) 0 0 0 (93.2%)
Gross margin, % — — — — — 38.47 27.49 40.61 58.21 52.81 57.77 +14.3 pt
EBT — — — — — (3) (226) (57) (46) (36) (57) +81.9%
EBT margin, % — — — — — (1.20) (1,715.46) (260.63) (288.81) (39.20) (37.02) (38.0) pt
Net income — 0 — — — (3) (190) (65) (50) (40) (48) n/m
Per share, $
Per share, $ Revenue — — — — — 430.89 2.60 1.93 1.28 6.57 8.95 (64.9%)
Earnings — — — — — (5.17) (37.48) (5.58) (3.71) (2.68) (2.88) (15.1%)
Cash flow — — — — — (2.14) 2.86 (1.22) (2.31) (1.55) (3.19) (7.7%)
Capex — — — — — 0.00 (1.24) (0.07) (0.08) (3.88) (1.92) n/m
Free cash flow — — — — — (2.14) 1.62 (1.30) (2.39) (5.44) (5.10) +26.2%
Book value — — — — — (42.26) 48.03 18.69 13.71 11.13 5.38 n/m
Shares, m — — — — — 1 5 11 12 14 16 +116.4%
Valuation, ×
Valuation, × P/E — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S — — — — — 0.00 10.69 2.91 4.55 2.74 1.81 4.2
P/B — — — — — 0.00 0.58 0.30 0.42 1.62 3.02 0.6
EV/Sales — — — — — 0.00 (1.27) 0.49 1.85 2.49 1.49 0.7
EV/FCF — — — — — 0.00 (1.18) 20.63 (1.04) (1.69) (2.58) 3.3
Cash, $m
Cash, $m Operating cash flow — — — — — (1) 15 (14) (29) (22) (55) +99.7%
Capex — — — — — (11) (6) (1) (1) (55) (33) +47.9%
Free cash flow — — — — — (1) 8 (15) (30) (76) (88) +173.1%
Balance, $m
Balance, $m Working capital — — — — — (3) 185 54 50 56 111 n/m
Net debt — — — — — 0 (167) (62) (52) (32) (59) +321.1%
Shareholders’ equity — — — — — (27) 243 210 171 156 93 n/m
Returns, %
Returns, % ROA — — — — — (0.29) (58.39) (22.15) (19.80) (17.97) (26.64) (17.7) pt
ROIC — — — — — 0.00 (53.67) (21.85) (19.03) (22.38) (110.30) (22.4) pt
ROE — — — — — (0.68) (176.01) (27.65) (24.27) (23.01) (38.55) (22.3) pt
People
People Employees — — — — — — — 320 285 98 — (44.7%)
Revenue/emp, $m — — — — — 0.00 0.00 0.07 0.06 0.94 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

Prenetics Global Limited vs peers in Packaged Foods (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
LWAY Lifeway Foods, Inc. $335.4M 30.7× 43.3× +24.10% (above 0%: growing) −96.43% (below 0%: shrinking) −598.84% (below 0%: shrinking) 19.47% 0.90% Compare
ENHA Enhanced Group Inc. $323.3M 10.8× — — n/m −483.42% (below 0%: shrinking) 100.00% (349.85%) Compare
PRE Prenetics Global Limited $273.0M — (loss-making) — (loss-making) +288.57% (above 0%: growing) n/m −297.16% (below 0%: shrinking) 64.97% (45.13%)
USNA USANA Health Sciences, Inc. $256.1M — (loss-making) — (loss-making) −3.64% (below 0%: shrinking) n/m +180.61% (above 0%: growing) 76.34% (0.70%) Compare
OTLY Oatly Group AB Sponsored ADR $245.7M — (loss-making) — (loss-making) +9.09% (above 0%: growing) n/m −254.68% (below 0%: shrinking) 34.14% (3.78%) Compare
BRCC BRC Inc. $244.5M — (loss-making) 42.0× +7.27% (above 0%: growing) n/m −141.35% (below 0%: shrinking) 37.14% (6.93%) Compare
BGS B&G Foods, Inc. $200.8M — (loss-making) — (loss-making) −9.70% (below 0%: shrinking) n/m +19.28% (above 0%: growing) 20.78% 9.02% Compare
NATR Nature's Sunshine Products, Inc. $180.5M 12.4× 11.5× −9.14% (below 0%: shrinking) −63.33% (below 0%: shrinking) −45.13% (below 0%: shrinking) 72.86% 4.53% Compare
NAGE Niagen Bioscience, Inc. $166.6M 16.1× 20.1× −19.99% (below 0%: shrinking) n/m −28.44% (below 0%: shrinking) 62.90% (5.84%) Compare
Median of peers $245.1M 14.2× 31.1× −3.64% — −93.24% 50.02% (2.24%)

All 68 Packaged Foods stocks →

Prenetics Global Limited (PRE) Latest News

19 Aug

Impact 3 · · Moby transcript

10 Jun

Impact 3 · · Zacks Small Cap Research

15 May

Impact 3 · · Moby transcript

8 Apr

Impact 3 · · Zacks Small Cap Research

6 Mar

Impact 4 · · GlobeNewswire
stockrow.com/PRE · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com